Your browser doesn't support javascript.
loading
Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis.
Dai, Yanmei; Jiang, Huijie; Jiang, Hao; Zhao, Sheng; Zeng, Xu; Sun, Ran; Zheng, Ruoshui.
Afiliação
  • Dai Y; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China.
  • Jiang H; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China. Electronic address: jianghuijie@hrbmu.edu.cn.
  • Jiang H; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China.
  • Zhao S; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China.
  • Zeng X; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China.
  • Sun R; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China.
  • Zheng R; Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, China.
Transl Oncol ; 14(12): 101238, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34628285

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2021 Tipo de documento: Article